Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2017 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Chilblain lupus 2"
Page 1
Cutaneous signs in COVID-19 patients: A review.
Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T. Wollina U, et al. Dermatol Ther. 2020 Sep;33(5):e13549. doi: 10.1111/dth.13549. Epub 2020 May 29. Dermatol Ther. 2020. PMID: 32390279 Free PMC article. Review.
Although more systematic investigations are warranted, it becomes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early d …
Although more systematic investigations are warranted, it becomes clear that some symptoms are clinical signs of a milder COVID-19 course …
Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis.
Chasset F, Bouaziz JD, Costedoat-Chalumeau N, Francès C, Arnaud L. Chasset F, et al. Br J Dermatol. 2017 Jul;177(1):188-196. doi: 10.1111/bjd.15312. Epub 2017 May 5. Br J Dermatol. 2017. PMID: 28112801 Review.
The odds ratio (OR) was used as the measure of association to compare the response rates between CLE subtypes and AMs. RESULTS: Among 1990 courses of treatment with AMs from 31 included studies, the overall response rate to AMs was 63% [95% confidence interval (CI) 55-70], …
The odds ratio (OR) was used as the measure of association to compare the response rates between CLE subtypes and AMs. RESULTS: Among 1990 …
Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
Zimmermann N, Wolf C, Schwenke R, Lüth A, Schmidt F, Engel K, Lee-Kirsch MA, Günther C. Zimmermann N, et al. JAMA Dermatol. 2019 Mar 1;155(3):342-346. doi: 10.1001/jamadermatol.2018.5077. JAMA Dermatol. 2019. PMID: 30673078 Free PMC article.
OBJECTIVES: To evaluate the clinical response to the Janus kinase inhibitor baricitinib in familial chilblain lupus and assess the effect of cold on patient fibroblasts. DESIGN, SETTING, AND PARTICIPANTS: In this case series, 3 patients with familial chilblain …
OBJECTIVES: To evaluate the clinical response to the Janus kinase inhibitor baricitinib in familial chilblain lupus and assess …
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
Zhang S, Song J, Yang Y, Miao H, Yang L, Liu Y, Zhang X, Liu Y, Wang T. Zhang S, et al. Pediatr Rheumatol Online J. 2021 Jan 6;19(1):1. doi: 10.1186/s12969-020-00490-1. Pediatr Rheumatol Online J. 2021. PMID: 33407657 Free PMC article.
These TREX1 variants have not been reported in previous studies and are predicted to be highly pathogenic. The proband was given tofacitinib that led to a marked improvement. ...
These TREX1 variants have not been reported in previous studies and are predicted to be highly pathogenic. The proband was given tofa …
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
Günther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA. Günther C, et al. Dermatology. 2009;219(2):162-6. doi: 10.1159/000222430. Epub 2009 May 28. Dermatology. 2009. PMID: 19478477
Thus, familial chilblain lupus represents the first monogenic form of cutaneous lupus erythematosus. Here we describe the unusual clinical course of this newly defined genodermatosis in an 18-year-old female member of the family in which familial chilblain …
Thus, familial chilblain lupus represents the first monogenic form of cutaneous lupus erythematosus. Here we describe the unus …